CAS 5746-04-3
:Nε-(Carbossimetil)lisina
- (2S)-2-Amino-6-(carboxymethylamino)hexanoic acid
- <span class="text-smallcaps">L</span>-Lysine, N<sup>6</sup>-(carboxymethyl)-
- L-Lysine,N6-(carboxymethyl)-
- Lysine, N<sup>6</sup>-(carboxymethyl)-, <span class="text-smallcaps">L</span>-
- Lysine,N6-(carboxymethyl)-, L- (8CI)
- N-(3-chloro-4-fluorophenyl)-2-[(2-chlorophenyl)sulfanyl]acetamide
- N6-(1-Carboxymethyl)-L-lysine
- N6-(Carboxymethyl)lysine
- N<sup>6</sup>-(Carboxymethyl)-<span class="text-smallcaps">L</span>-lysine
- N<sup>6</sup>-(Carboxymethyl)lysine
- N<sup>ε</sup>-(Carboxymethyl)lysine
- Ne-(Carboxymethyl)lysine
- e-(Carboxymethyl)lysine
- N6-(Carboxymethyl)-L-lysine
- Vedi altri sinonimi
(2S)-2-Amino-6-(carboxymethylamino)hexanoic acid hydrochloride
CAS:(2S)-2-Amino-6-(carboxymethylamino)hexanoic acid hydrochloridePurezza:95%Colore e forma:SolidPeso molecolare:240.68g/molRef: 4Z-L-138025
5mgPrezzo su richiesta10mgPrezzo su richiesta25mgPrezzo su richiesta50mgPrezzo su richiesta100mgPrezzo su richiestaNε-(1-Carboxymethyl)-L-lysine
CAS:Applications CEL and CML are two stable, nonenzymatic chemical modifications of protein lysine residues resulting from glycation and oxidation reactions.
References Fu, M.X., et al.: J. Biol. Chem., 271, 9982 (1996), Ahmed M.U., et al.: Biochem.J., 324, 565 (1997), Schleicher, E.D., et al.: J. Clin. Invest., 99, 457 (1997), Shibayama, R., et al.: Diabetes, 48, 1842 (1999),Formula:C8H16N2O4Colore e forma:NeatPeso molecolare:204.22N-ε-(1-Carboxymethyl)-L-lysine
CAS:N-ε-(1-Carboxymethyl)-L-lysine (NEM) is a versatile building block that is used in the synthesis of complex compounds. It is a reagent and speciality chemical that can be used as an intermediate to produce other useful chemicals or as a reaction component. It has been shown to be useful in the synthesis of peptides, oligonucleotides, and organic molecules. NEM has also been shown to have high quality and purity, making it a useful scaffold for further research into new compounds.
Formula:C8H16N2O4Purezza:Min. 97%Colore e forma:White PowderPeso molecolare:204.22 g/mol(2S)-2-amino-6-[(carboxymethyl)amino]hexanoic acid
CAS:Formula:C8H16N2O4Purezza:98%Colore e forma:White crystalline powderPeso molecolare:204.226Nε-(Carboxymethyl)-L-lysine-2,6,6-d3
CAS:Prodotto controllatoFormula:C8H13D3N2O4Colore e forma:NeatPeso molecolare:207.24Nε-(1-Carboxymethyl)-L-lysine
CAS:Nε-(1-Carboxymethyl)-L-lysine (CML), an advanced glycation end product (AGE), is formed through the oxidative modification of glycated proteins under conditions of oxidative stress.1,2,3 Its levels escalate with age, diabetes, cancer, vascular diseases, and various pathologies associated with oxidative stress.1,4,5 CML interacts with the membrane-bound receptor for AGEs (RAGE), initiating signaling via MAPKs and NF-κB pathways. Conversely, a truncated version of RAGE generates a soluble protein that sequesters CML, thereby diminishing this signaling.6,7Formula:C8H16N2O4Colore e forma:SolidPeso molecolare:204.2






